DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
Trial details
- Registry ID
- NCT07024693
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyNCT07024693 | DSGN | Phase 2 | Recruiting | 2027-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |